Changming (Sherman) Xia, Ph.D., is currently the Director of Biostatistics at Regeneron, leading the franchise for Dupixent/dupilumab in Immunology and Inflammation. They have previously served as a Biostatistics Consultant at the University of Rochester Medical Center and held various positions including Senior Research Statistician at AbbVie and Statistical Reviewer at the FDA. With an extensive educational background, Xia is pursuing multiple master's degrees while holding a Ph.D. from the University of Rochester School of Medicine and Dentistry and a certificate from the University of Pennsylvania. Prior to their current role, they advanced analytics in the medical affairs area, focusing on respiratory and gastrointestinal conditions at Regeneron.
This person is not in any teams
This person is not in any offices